BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 11353842)

  • 1. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
    Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway.
    Lamothe B; Yamada M; Schaeper U; Birchmeier W; Lax I; Schlessinger J
    Mol Cell Biol; 2004 Jul; 24(13):5657-66. PubMed ID: 15199124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells.
    Cross MJ; Lu L; Magnusson P; Nyqvist D; Holmqvist K; Welsh M; Claesson-Welsh L
    Mol Biol Cell; 2002 Aug; 13(8):2881-93. PubMed ID: 12181353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
    Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
    Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
    Wang X; Weng LP; Yu Q
    Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
    Hanafusa H; Torii S; Yasunaga T; Nishida E
    Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation.
    Klint P; Kanda S; Kloog Y; Claesson-Welsh L
    Oncogene; 1999 Jun; 18(22):3354-64. PubMed ID: 10362356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
    Wu Y; Chen Z; Ullrich A
    Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
    Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
    EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of fibroblast growth factor (FGF)-stimulated mitogenesis by a FGF receptor-1-derived phosphopeptide.
    Dunican DJ; Williams EJ; Howell FV; Doherty P
    Cell Growth Differ; 2001 May; 12(5):255-64. PubMed ID: 11373272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
    Li X; Brunton VG; Burgar HR; Wheldon LM; Heath JK
    J Cell Sci; 2004 Dec; 117(Pt 25):6007-17. PubMed ID: 15564375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction.
    Kurokawa K; Iwashita T; Murakami H; Hayashi H; Kawai K; Takahashi M
    Oncogene; 2001 Apr; 20(16):1929-38. PubMed ID: 11360177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of major ERK-related phosphorylation sites in Gab1.
    Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
    Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation.
    Hadari YR; Kouhara H; Lax I; Schlessinger J
    Mol Cell Biol; 1998 Jul; 18(7):3966-73. PubMed ID: 9632781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
    Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
    Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
    Gupta RW; Mayer BJ
    Oncogene; 1998 Oct; 17(17):2155-65. PubMed ID: 9811447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways.
    Hadari YR; Gotoh N; Kouhara H; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8578-83. PubMed ID: 11447289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.
    Maeda K; Murakami H; Yoshida R; Ichihara M; Abe A; Hirai M; Murohara T; Takahashi M
    Biochem Biophys Res Commun; 2004 Oct; 323(1):345-54. PubMed ID: 15351743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.